London
· Delayed Price · Currency is GBP · Price in USD Moderna Statistics
Total Valuation
Moderna has a market cap or net worth of GBP 12.20 billion. The enterprise value is 5.89 billion.
| Market Cap | 12.20B |
| Enterprise Value | 5.89B |
Important Dates
The next estimated earnings date is Thursday, February 27, 2025.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.20% |
| Shares Change (QoQ) | +3.91% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 347.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.55 |
| EV / Sales | 1.44 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.00 |
Financial Position
The company has a current ratio of 4.39, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.39 |
| Quick Ratio | 3.95 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.34 |
| Interest Coverage | -112.21 |
Financial Efficiency
Return on equity (ROE) is -17.52% and return on invested capital (ROIC) is -11.94%.
| Return on Equity (ROE) | -17.52% |
| Return on Assets (ROA) | -9.55% |
| Return on Invested Capital (ROIC) | -11.94% |
| Return on Capital Employed (ROCE) | -19.80% |
| Revenue Per Employee | 676,953 |
| Profits Per Employee | -296,308 |
| Employee Count | 5,600 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 13.50 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.83% in the last 52 weeks. The beta is 1.69, so Moderna's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | -60.83% |
| 50-Day Moving Average | 40.80 |
| 200-Day Moving Average | 81.84 |
| Relative Strength Index (RSI) | 49.99 |
| Average Volume (20 Days) | 67,420 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.13 |
Income Statement
In the last 12 months, Moderna had revenue of GBP 3.79 billion and -1.66 billion in losses. Loss per share was -4.34.
| Revenue | 3.79B |
| Gross Profit | -1.04B |
| Operating Income | -2.01B |
| Pretax Income | -1.76B |
| Net Income | -1.66B |
| EBITDA | -1.76B |
| EBIT | -2.01B |
| Loss Per Share | -4.34 |
Balance Sheet
The company has 5.12 billion in cash and 1.01 billion in debt, giving a net cash position of 5.85 billion.
| Cash & Cash Equivalents | 5.12B |
| Total Debt | 1.01B |
| Net Cash | 5.85B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 8.90B |
| Book Value Per Share | 23.11 |
| Working Capital | 5.57B |
Cash Flow
In the last 12 months, operating cash flow was -2.39 billion and capital expenditures -558.83 million, giving a free cash flow of -2.95 billion.
| Operating Cash Flow | -2.39B |
| Capital Expenditures | -558.83M |
| Free Cash Flow | -2.95B |
| FCF Per Share | n/a |
Margins
Gross margin is -27.55%, with operating and profit margins of -53.00% and -43.77%.
| Gross Margin | -27.55% |
| Operating Margin | -53.00% |
| Pretax Margin | -46.31% |
| Profit Margin | -43.77% |
| EBITDA Margin | -46.49% |
| EBIT Margin | -53.00% |
| FCF Margin | n/a |
Dividends & Yields
Moderna does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.20% |
| Shareholder Yield | 0.20% |
| Earnings Yield | -13.60% |
| FCF Yield | -24.19% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Moderna has an Altman Z-Score of 7.28.
| Altman Z-Score | 7.28 |
| Piotroski F-Score | n/a |